{
    "Title": "Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial",
    "URL": "https://doi.org/10.1371/journal.pntd.0004880",
    "Published": "September 14, 2016",
    "Subject_Areas": [
        "Drug therapy",
        "Blood",
        "Pharmacokinetics",
        "Leishmaniasis",
        "Adverse events",
        "Adverse reactions",
        "Body mass index",
        "Kala-azar"
    ],
    "Authors": {
        "Monique Wasunna": [
            "Drugs for Neglected Diseases initiative, Nairobi, Kenya",
            "Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya"
        ],
        "Simon Njenga": [
            "Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya"
        ],
        "Manica Balasegaram": [
            "Drugs for Neglected Diseases initiative, Geneva, Switzerland"
        ],
        "Neal Alexander": [
            "MRC Tropical Epidemiology Group, London School of Hygiene & Tropical Medicine, London, United Kingdom"
        ],
        "Raymond Omollo": [
            "Drugs for Neglected Diseases initiative, Nairobi, Kenya"
        ],
        "Tansy Edwards": [
            "MRC Tropical Epidemiology Group, London School of Hygiene & Tropical Medicine, London, United Kingdom"
        ],
        "Thomas P. C. Dorlo": [
            "Department of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, the Netherlands"
        ],
        "Brima Musa": [
            "Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan"
        ],
        "Mohammed Hassan Sharaf Ali": [
            "Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan"
        ],
        "Mohammed Yasein Elamin": [
            "Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan"
        ],
        "George Kirigi": [
            "Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya"
        ],
        "Rashid Juma": [
            "Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya"
        ],
        "Anke E. Kip": [
            "Department of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, the Netherlands",
            "Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands"
        ],
        "Gerard J. Schoone": [
            "KIT Biomedical Research, Amsterdam, the Netherlands"
        ],
        "Asrat Hailu": [
            "College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia"
        ],
        "Joseph Olobo": [
            "Department of Medical Microbiology, Leishmaniasis Unit, College of Health Sciences, Makerere University, Kampala, Uganda"
        ],
        "Sally Ellis": [
            "Drugs for Neglected Diseases initiative, Geneva, Switzerland"
        ],
        "Robert Kimutai": [
            "Drugs for Neglected Diseases initiative, Nairobi, Kenya",
            "Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya"
        ],
        "Susan Wells": [
            "Drugs for Neglected Diseases initiative, Geneva, Switzerland"
        ],
        "Eltahir Awad Gasim Khalil": [
            "Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan"
        ],
        "Nathalie Strub Wourgaft": [
            "Drugs for Neglected Diseases initiative, Geneva, Switzerland"
        ],
        "Fabiana Alves": [
            "Drugs for Neglected Diseases initiative, Geneva, Switzerland"
        ],
        "Ahmed Musa": [
            "Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan"
        ]
    }
}